Constitutive activating mutations of the human Luteinizing hormone/chorionic gonadotropin hormone receptor (LHR) causes familial male-limited precocious puberty (FMPP). In collaboration with Dr. Malcolm Martin, Georgetown University, and Dr. Ellen Leschek, Developmental Endocrinology Branch, we have identified two FMPP patients who developed testicular neoplasia. To study the impact of constitutive activation of the LH/hCG signaling pathway on spermatogenesis and sexual development, and the potential tumorigenic effect of a constitutively activated LHR, we have generated an in vitro cell model and are in the process of generating a transgenic animal model. MA-10 cells were transfected with activating LHR mutations. The profile of expressed genes in cells expressing the mutated LHR was compared with that of control cells. Preliminary studies of one mutated LHR indicated up-regulation of genes associated with cell proliferation and down-regulation of genes associated with differentiation. Interestingly, several genes known to be involved in spermatogenesis were also down-regulated in cells expressing the mutated LHR. This study is being repeated with different mutated LHR genes with analysis employing a more extensive mouse cDNA microarray. We are generating constructs of LHR carrying activating mutations for introduction into mouse ES cells to generate a transgenic animal model of FMPP for the study of the impact of constitutively activated LHR gene on spermatogenesis and sexual development.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
U.S. National Inst/Child Hlth/Human Dev
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kaler, Stephen G (2016) Microbial peptide de-coppers mitochondria: implications for Wilson disease. J Clin Invest 126:2412-4
Meng, Xing-Li; Rennert, Owen M; Chan, Wai-Yee (2007) Human chorionic gonadotropin induces neuronal differentiation of PC12 cells through activation of stably expressed lutropin/choriogonadotropin receptor. Endocrinology 148:5865-73
Leung, Michael Yiu-Kwong; Steinbach, Peter J; Bear, Deborah et al. (2006) Biological effect of a novel mutation in the third leucine-rich repeat of human luteinizing hormone receptor. Mol Endocrinol 20:2493-503
Chan, Wai-Yee (2005) Disorders of sexual development caused by luteinizing hormone receptor mutations. Beijing Da Xue Xue Bao 37:32-8
Ifon, Ekwere T; Pang, Alan L Y; Johnson, Warren et al. (2005) U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int 5:19
Leschek, E W; Chan, W Y; Diamond, D A et al. (2001) Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. J Pediatr 138:949-51
Sandrini, F; Farmakidis, C; Kirschner, L S et al. (2001) Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin. J Clin Endocrinol Metab 86:5433-7
Wu, S M; Leschek, E W; Rennert, O M et al. (2000) Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Front Biosci 5:D343-52
Wu, S M; Chan, W Y (1999) Male pseudohermaphroditism due to inactivating luteinizing hormone receptor mutations. Arch Med Res 30:495-500